vexibinol has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du Nguyen, H; Horaguchi, Y; Kasanami, Y; Kawabata, A; Kitamura, S; Nishikawa, H; Okada, T; Sekiguchi, F; Toyooka, N; Tsubota, M; Yamaoka, S; Yoshida, S | 1 |
| Tong, Y; Wang, H; Xia, B; Xiao, D | 1 |
2 other study(ies) available for vexibinol and Disease Models, Animal
| Article | Year |
|---|---|
Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
Topics: Action Potentials; Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Drug Design; Flavonoids; HEK293 Cells; Humans; Inhibitory Concentration 50; Male; Mice; Neuralgia; Patch-Clamp Techniques; Structure-Activity Relationship | 2018 |
Involvement of mTOR-related signaling in antidepressant effects of Sophoraflavanone G on chronically stressed mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Chronic Disease; Depression; Disease Models, Animal; Flavanones; Food Preferences; Hindlimb Suspension; Hippocampus; Male; Mice; Mice, Inbred BALB C; Signal Transduction; Sirolimus; Stress, Psychological; Sucrose; TOR Serine-Threonine Kinases | 2020 |